Datavault: A Speculative AI Play, But Beware of Volatility Datavault's technology is supported by deals with companies like IBM, which is committing millions of resources to support platform expansion. MarketBeat · Oct 13, 2025
This Penny Stock Is Surging on Supercomputer and Bitcoin Plans. Should You Buy It Now? Datavault stock soars as the company secures a $150 million strategic investment from Scilex Holding. But does that make DVLT shares worth owning at current levels? Barchart · Sep 26, 2025
3 Stocks Under $2 That Will More Than Double in the Next 12 Months, According to Wall Street Surging inflation, interest rate hikes, and geopolitical uncertainties have recently put the stock market under pressure. So, it could be wise to bet on low-priced stocks that possess solid rebound prospects. Wall Street Analysts expect low-priced stocks PaySign, Inc. (PAYS), Sorrento Therapeutics, Inc. (SRNE), and National CineMedia, Inc. (NCMI) to… StockNews.com · May 27, 2022
Sorrento's Scilex Unit Begins Mid-stage Study of Lower Back Pain Drug Scilex Holding Company, a Sorrento Company (NASDAQ: SRNE) announced dosing of the first patient in a Phase 2 study of its drug candidate in patients with SP-103 in subjects with acute low back pain (LBP). Benzinga · May 18, 2022
Vickers Venture SPAC To Merge With Sorrento Therapeutics' Pain-Focused Subsidiary Vickers Venture Partners' special purpose acquisition company Vickers Vantage Corp I (NASDAQ: VCKA) will merge with Scilex Holding Company, focused on developing and commercializing non-opioid therapies for acute and chronic pain. Benzinga · Mar 18, 2022